News

A simple blood test can tell which patients will rapidly develop severe Alzheimer's, a new study has revealed.
Eli Lilly and Co. (LLY) announced detailed results from QWINT-1, QWINT-3, and QWINT-4 Phase 3 clinical trials evaluating the safety and efficacy of investigational once-weekly insulin efsitora alfa ...
EAU guidelines offer updated guidance on diagnosis, treatment, & follow-up of patients with metastatic & muscle-invasive ...
Discover the history, evolution, and importance of clinical trials, from James Lind's scurvy study to modern registry ...
In a major cardiac imaging trial involving over 600 patients, the AI was able to digitize thousands of pages of patient ...
The Mater Hospital’s Centre for AI and Digital Health has been brought about through the collaboration of consultants, ...
Weight-loss jabs have grown massively in popularity over the past year, but a team of scientists has now found that the ...